Edition:
United States

Global Blood Therapeutics Inc (GBT.OQ)

GBT.OQ on NASDAQ Stock Exchange Global Select Market

49.30USD
17 Aug 2018
Change (% chg)

$-0.65 (-1.30%)
Prev Close
$49.95
Open
$49.65
Day's High
$49.85
Day's Low
$48.75
Volume
180,867
Avg. Vol
286,222
52-wk High
$68.05
52-wk Low
$26.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.780
Mar '18 0.00 -0.870
FY 2017 Dec '17 0.00 -0.942
Sep '17 0.00 -0.660
Jun '17 0.00 -0.555
Mar '17 0.00 -0.596
FY 2016 Dec '16 0.00 -0.743
Sep '16 0.00 -0.577
Jun '16 0.00 -0.582
Mar '16 0.00 -0.564
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 12 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 12 0.00 0.00 0.00 0.00
Year Ending Dec-18 14 0.00 0.00 0.00 0.00
Year Ending Dec-19 14 11.25 157.50 0.00 15.30
Earnings (per share)
Quarter Ending Sep-18 14 -0.85 -0.73 -1.08 -0.66
Quarter Ending Dec-18 14 -0.90 -0.73 -1.17 -0.68
Year Ending Dec-18 14 -3.41 -3.10 -3.91 -2.90
Year Ending Dec-19 14 -3.60 -1.01 -5.14 -3.33
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 99.36 30.45
P/E High - Last 5 Yrs. -- 272.05 47.36
P/E Low - Last 5 Yrs. -- 95.21 24.74
Beta -- 0.78 0.84
Price to Sales (TTM) -- 126.22 5.98
Price to Book (MRQ) 5.05 13.00 3.69
Price to Tangible Book (MRQ) 5.07 22.28 5.63
Price to Cash Flow (TTM) -- 64.21 20.97
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.37 1.78
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.47 -5.93
Payout Ratio(TTM) -- 6.14 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 158.89 7.18
Sales (TTM) vs TTM 1 Yr. Ago -- 91.20 12.05
Sales - 5 Yr. Growth Rate -- 24.34 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago -40.67 74.27 23.85
EPS (TTM) vs TTM 1 Yr. Ago -31.59 -- --
EPS - 5 Yr. Growth Rate -- 23.23 7.52
Capital Spending - 5 Yr. Growth Rate -- 36.95 8.06

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.73 2.50
Current Ratio (MRQ) 22.06 5.42 3.53
LT Debt to Equity (MRQ) 0.00 19.75 11.27
Total Debt to Equity (MRQ) 0.00 23.48 14.23
Interest Coverage (TTM) -- -186.89 31.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 57.13 55.23
Gross Margin - 5 Yr. Avg. -- 52.64 53.33
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -189.34 15.82
Operating Margin (TTM) -- -673.76 3.86
Operating Margin - 5 Yr. Avg. -- -202.74 10.95
Pre-Tax Margin (TTM) -- -665.74 4.16
Pre-Tax Margin - 5 Yr. Avg. -- -203.67 11.12
Net Profit Margin (TTM) -- -655.99 0.98
Net Profit Margin - 5 Yr. Avg. -- -201.27 7.47
Effective Tax Rate (TTM) -- 12.18 20.36
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 5,071,848 718,909,906
Net Income/Employee (TTM) -1,032,197 -6,208,777 83,624,743
Receivable Turnover (TTM) -- 6.39 5.38
Inventory Turnover (TTM) -- 2.25 3.51
Asset Turnover (TTM) 0.00 0.42 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -36.08 1.88 10.04
Return on Assets - 5 Yr. Avg. -- 2.31 10.94
Return on Investment (TTM) -37.81 2.89 12.63
Return on Investment - 5 Yr. Avg. -- 1.68 14.14
Return on Equity (TTM) -38.50 1.65 14.82
Return on Equity - 5 Yr. Avg. -- -6.94 15.50
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -11.34 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Global Blood Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 19.23 17.21 99 24
13 Week 6.94 1.79 99 51
26 Week -21.68 -24.92 99 49
52 Week 78.62 52.29 99 82
YTD 25.29 17.53 99 79
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 287
Total Shares Held: 53,025,170
3 Mo. Net Change: 2,012,041
# New Positions: 54
# Closed Positions: 26
# Increased Positions: 169
# Reduced Positions: 86
# Net Buyers: 83
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.